Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population

Exclusion Criteria

• •Subject having presented an infectious pathology requiring antibiotic treatment in the previous 3 months.
• •Subject with a dysimmune pathology.
• •Subject having had treatment with an immunomodulatory molecule or chemotherapy within 60 days before inclusion in the research or whose indication is planned for the duration of the research.
• •Subject with a chronic digestive pathology or having undergone bariatric surgery in the previous year.
• •Subject on laxative.
• •Subject living in a medical institution.
• •Subject under legal protection, guardianship or curatorship.
• •Subject and/or their legal representative (if a minor patient) unable to express consent
• •Taking antibiotics during the inclusion period, or laxative or any other treatment having a significant impact on the microbiota